{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:26:37Z","timestamp":1794018397523,"version":"4.8.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.humpath.2026.106229","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:09:11Z","timestamp":1785856151000},"page":"106229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SMARCA4-altered malignancies: Cytologic diagnostic challenges and clinicopathologic correlation"],"prefix":"10.1016","volume":"177","author":[{"given":"Behtash G.","family":"Nezami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0760-3950","authenticated-orcid":false,"given":"Xiaoqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.humpath.2026.106229_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500447","article-title":"Mammalian SWI\/SNF chromatin remodeling complexes and cancer: mechanistic insights gained from human genomics","volume":"1","author":"Kadoch","year":"2015","journal-title":"Sci Adv"},{"issue":"10","key":"10.1016\/j.humpath.2026.106229_bib2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ng.3399","article-title":"SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas","volume":"47","author":"Le Loarer","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2026.106229_bib3","series-title":"WHO classification of tumours: thoracic tumours","first-page":"111","article-title":"Thoracic SMARCA4-deficient undifferentiated tumour","author":"Yoshida","year":"2021"},{"issue":"6001","key":"10.1016\/j.humpath.2026.106229_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1196333","article-title":"Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma","volume":"330","author":"Jones","year":"2010","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.humpath.2026.106229_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ng.2928","article-title":"Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4","volume":"46","author":"Ramos","year":"2014","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.humpath.2026.106229_bib6","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"Imielinski","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2026.106229_bib7","article-title":"Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor","volume":"12","author":"Zhou","year":"2024","journal-title":"PeerJ"},{"issue":"4","key":"10.1016\/j.humpath.2026.106229_bib8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.pathol.2023.12.414","article-title":"SMARCA4 deficiency and mutations are frequent in large cell lung carcinoma and are prognostically significant","volume":"56","author":"Cheung","year":"2024","journal-title":"Pathology"},{"issue":"4","key":"10.1016\/j.humpath.2026.106229_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jasc.2022.04.001","article-title":"Cytomorphologic and immunophenotypical analysis of SMARCA4 (BRG1)-deficient non-small cell lung carcinoma","volume":"11","author":"Ogunbona","year":"2022","journal-title":"J Am Soc Cytopathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106229_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s12967-018-1733-y","article-title":"Implementing a comprehensive translational oncology platform: from molecular testing to actionability","volume":"16","author":"Mitri","year":"2018","journal-title":"J Transl Med"},{"issue":"21","key":"10.1016\/j.humpath.2026.106229_bib11","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-20-1825","article-title":"The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer","volume":"26","author":"Schoenfeld","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.humpath.2026.106229_bib12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41467-019-08380-1","article-title":"SMARCA4 loss is synthetic lethal with CDK4\/6 inhibition in non-small cell lung cancer","volume":"10","author":"Xue","year":"2019","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.humpath.2026.106229_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081920","article-title":"Perspectives and issues in the assessment of SMARCA4 deficiency in the management of lung cancer patients","volume":"10","author":"Armon","year":"2021","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.humpath.2026.106229_bib14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/cncy.22581","article-title":"Cytomorphologic features of SMARCA4-deficient non-small cell lung carcinoma and correlation with immunohistochemical and molecular features","volume":"130","author":"Sun","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.humpath.2026.106229_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.106007","article-title":"Detection of targetable genetic alterations in SMARCA4-deficient neoplasms of the lung - further evidence of a relationship between SMARCA4-deficient undifferentiated tumor and non-small cell carcinoma","volume":"167","author":"D'Ambrosio","year":"2026","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106229_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000510323","article-title":"Cytology of SMARCA4-Deficient thoracic neoplasms: comparative analysis of SMARCA4-Deficient non-small cell lung carcinomas and SMARCA4-Deficient thoracic sarcomas","volume":"65","author":"Nambirajan","year":"2021","journal-title":"Acta Cytol"},{"issue":"4","key":"10.1016\/j.humpath.2026.106229_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/PAS.0000000000001188","article-title":"SMARCA4-deficient thoracic sarcomas: clinicopathologic study of 30 cases with an emphasis on their nosology and differential diagnoses","volume":"43","author":"Perret","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.humpath.2026.106229_bib18","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1007\/s00330-019-06017-x","article-title":"Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients","volume":"29","author":"Crombe","year":"2019","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.humpath.2026.106229_bib19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jtho.2019.10.023","article-title":"SMARCA4-Deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas","volume":"15","author":"Rekhtman","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"24","key":"10.1016\/j.humpath.2026.106229_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71442","article-title":"Prognostic implications of SMARCA4, ARID1A, and other BAF mutations in non-small cell lung cancer","volume":"14","author":"Khalil","year":"2025","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.humpath.2026.106229_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/cncy.22919","article-title":"Fine-needle aspiration and effusion cytology of thoracic SMARCA4-deficient undifferentiated tumor and SMARCA4-deficient non-small cell lung carcinoma: a multi-institutional experience with 27 patients","volume":"133","author":"Zalles","year":"2025","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106229_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/his.15063","article-title":"NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumour: facts and controversies","volume":"84","author":"Yoshida","year":"2024","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.humpath.2026.106229_bib23","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1038\/s41467-020-19402-8","article-title":"Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients","volume":"11","author":"Fernando","year":"2020","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.humpath.2026.106229_bib24","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jtho.2021.03.024","article-title":"SMARCA4 and other SWItch\/Sucrose NonFermentable family genomic alterations in NSCLC: clinicopathologic characteristics and outcomes to immune checkpoint inhibition","volume":"16","author":"Alessi","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.humpath.2026.106229_bib25","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/1759-7714.13070","article-title":"Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: a case report","volume":"10","author":"Naito","year":"2019","journal-title":"Thorac Cancer"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772600198X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772600198X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:14:32Z","timestamp":1794017672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681772600198X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":25,"alternative-id":["S004681772600198X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106229","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SMARCA4-altered malignancies: Cytologic diagnostic challenges and clinicopathologic correlation","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106229"}}